Peptide Therapeutics Market Expected to Reach USD 23.7 Billion Globally in 2020


Posted April 29, 2015 by danny123

Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020

 
The global peptide therapeutics market report provides detailed analysis, market size, and forecast for therapeutic peptides approved for various indications. The market is studied from four major perspectives: applications, route of administration, marketing status, and geography. Application segments of the global peptide therapeutics market have been further sub-segmented by major branded peptide drugs approved by regulatory authorities across the globe. Various applications considered in the report include metabolic disorders, hematological disorders, cancer, cardiovascular disorders, central nervous system disorders, infection, gastrointestinal disorders, respiratory disorders, acromegaly, and others. Market size and forecast for leading drugs such as Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza, and Zoladex has been included along with in-depth market analysis. Segmentation by marketing status explains the impact of generic drugs on the overall peptide therapeutics market. Further, market segmentation of peptide drugs by route of administration provides quantitative insights into the growing demand for convenient methods for peptide drug administration. Details on peptide drug approvals, patent expiry, mergers, acquisitions, strategic agreements, disease prevalence and other major events have been included in respective market segments.

Browse the full Peptide Therapeutics Market Report at :
http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

The global peptide therapeutics market report provides market estimation and forecast for more than fifteen branded peptide drugs in the market. Further, the market is also segmented by major geographical regions, which include North America, Europe, Asia Pacific and Rest of the World. A list of pipeline drugs has also been provided in the report. This list includes potential peptide drugs in phases I, II, and III of clinical development.

Emerging trends in global peptide API production, such as development of new peptide API production technologies and strategic agreements in peptide API production have been discussed. The report also profiles key peptide API suppliers. An overview of regulatory policies has also been provided in the global peptide therapeutics market report. Based on our in-depth analysis and comprehensive market study, key factors driving and restraining the market have been discussed. A detailed event impact analysis considers regulatory approvals, patent expiry of major drugs, drug recalls and other factors in the peptide therapeutics market. The research study also incorporates the competitive scenario in these regions, where market share of seven major players in 2013 has also been provided. Relevant recommendations have been provided for new entrants as well as existing market players to help them establish a strong presence in the market and increase their share. Fifteen major players have been profiled which include Amgen, Inc., AstraZeneca plc, Bachem Holding AG, CordenPharma International GmbH, Eli Lilly & Co., Ipsen S.A., Lonza, Inc., Merck & Co., Novartis AG, Novo Nordisk A/S, PolyPeptide Group, Roche Holdings AG, Sanofi, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Limited. The 104 pages global peptide therapeutics market report includes 30 figures and charts, and 14 tables.

Browse the full Peptide Therapeutics Market press release at :
http://www.transparencymarketresearch.com/pressrelease/peptide-therapeutics-market.htm

Market size and forecast in terms of USD million for each segment in the global peptide therapeutics market has been provided for the period 2012 to 2020, considering 2012 and 2013 as the base years. The report also provides the compounded annual growth rate (CAGR %) for each market segment for the forecast period 2014 to 2020. The peptide therapeutics market has been estimated using a bottom-up approach, where market size estimates for each drug have been summed-up to arrive at the total market size. Market forecasts have been derived considering the effect of generic drug approvals, drug recalls, disease prevalence, patent term extension, box warning and various other factors. Inputs from industry experts and key opinion leaders have validated and further refined our market estimates.

Get Free Sample Report Peptide Therapeutics Market :
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=418

The global peptide therapeutics market has been segmented as below:

Global Peptide Therapeutics Market, by Application

Cancer

Zoladex (goserelin)

Velcade (bortezomib)

Lupron/ Enantone/ Eligard (leuprorelin)

Others

Cardiovascular

Angiomax (bivalirudin)

Integrilin (eptifibatide)

Central Nervous System

Copaxone (glatiramer)

Metabolic Disorders

Victoza (liraglutide)

Byetta (exenatide)

Others

Infection

Incivek (telaprevir)

Victrelis (boceprevir)

Hematological Disorders

Firazyr (icatibant)

Kalbitor (ecallantide)

Gastrointestinal Disorders

Gattex (teduglutide)

Linzess (linaclotide)

Respiratory Disorders

Acromegaly

Other Applications

Global Peptide Therapeutics Market, by Route of Administration

Parenteral

Oral

Global Peptide Therapeutics Market, by Marketing Status

Branded

Generic

Global Peptide Therapeutics Market, by Geography

North America

Europe

Asia Pacific

Rest of the World

About Us :

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mr.Nachiket
Website http://www.transparencymarketresearch.com/
Country United States
Categories Health , Reports , Research
Tags global peptide therapeutics industry , global peptide therapeutics market research report , peptide therapeutics market , peptide therapeutics market analysis , peptide therapeutics market research report
Last Updated April 29, 2015